Previously Aired - April 16, 2020 Join us for an informative discussion about how the concurrent use of AI improves sensitivity, specificity and reading time when reading Digital Breast Tomosynthesis (DBT) cases. Dr. Mark Traill will discuss real-world experiences and clinical perspectives in breast health solutions powered by artificial intelligence. Built on the latest deep learning and artificial intelligence (AI) technology, ProFound AI is clinically proven to assist radiologists in addressing the challenges of reading tomosynthesis cases by improving cancer detection rates, reducing false positives and unnecessary patient recalls all while decreasing reading times.
Sed ut perspiciatis unde omnis iste natus error sit voluptatem!
Nemo enim ipsam voluptatem quia voluptas sit odit aut fugit!
Ut enim ad minima veniam, quis nostrum exercitationem ullam!
<--Speaker Title Here-->
<--Speaker Title Here-->
<--Speaker Title Here-->